An overview of prognostic factors for long-term survivors of breast cancer Isabelle SoerjomataramMarieke W. J. LouwmanJan Willem W. Coebergh Review Open access 22 March 2007 Pages: 309 - 330
Clonality of lobular carcinoma in situ (LCIS) and metachronous invasive breast cancer Sebastian AulmannRoland PenzelHans Peter Sinn Preclinical Study 23 March 2007 Pages: 331 - 335
Role of Fra-2 in breast cancer: influence on tumor cell invasion and motility Karin Milde-LangoschStanislava JankeThomas Löning Preclinical Study 28 March 2007 Pages: 337 - 347
Unique resistance of breast carcinoma cell line T47D to TRAIL but not anti-Fas is linked to p43cFLIPL Natalya V. GusevaOskar W. RokhlinMichael B. Cohen Preclinical Study 24 April 2007 Pages: 349 - 357
Inhibition of mammary tumorigenesis in the C3(1)/SV40 mouse model by green tea Hoyee LeongPriya S. MathurGeoffrey L. Greene Preclinical Study 05 May 2007 Pages: 359 - 369
Risk of neoplastic transformation in asymptomatic radial scar. Analysis of 117 cases Erminia ManfrinAndrea RemoFranco Bonetti Preclinical Study 25 April 2007 Pages: 371 - 377
Breast cancer subpopulation with high risk of internal mammary lymph nodes metastasis: analysis of 2,269 Chinese breast cancer patients treated with extended radical mastectomy Ou HuangLiping WangZhenzhou Shen Clinical Study 25 April 2007 Pages: 379 - 387
Hormone replacement therapy, mammography screening and changing age-specific incidence rates of breast cancer: an ecological study comparing two European populations H. M. VerkooijenV. C. M. KootC. Bouchardy Epidemiology 13 March 2007 Pages: 389 - 395
Diffusion of aromatase inhibitors for breast cancer therapy between 1996 and 2003 in the Cancer Research Network Erin J. AielloDiana S. M. BuistAnn M. Geiger Epidemiology 28 March 2007 Pages: 397 - 403
Advanced stages and poorly differentiated grade are associated with an increased risk of HER2/neu positive breast carcinoma only in White women: findings from a prospective cohort study of African-American and White-American women Azadeh StarkAlissa KapkeUsha Raju Epidemiology 13 April 2007 Pages: 405 - 414
Estrogen receptor α polymorphisms and postmenopausal breast cancer risk A. M. González-Zuloeta LaddA. Arias VásquezC. M. van Duijn Epidemiology Open access 24 April 2007 Pages: 415 - 419
Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk Yong ZhuRichard G. StevensTongzhang Zheng Epidemiology 24 April 2007 Pages: 421 - 425
Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy Alexander KatalinicRajesh Rawal Epidemiology 24 April 2007 Pages: 427 - 430
Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patients Irene KonstantopoulouTheodore RampiasDrakoulis Yannoukakos Epidemiology 24 April 2007 Pages: 431 - 441
The development of a predictive model to estimate cardiotoxic risk for patients with metastatic breast cancer receiving anthracyclines George DranitsarisDaniel RaysonGreg Reardon Epidemiology 03 November 2007 Pages: 443 - 450
Cardiotoxicity and anthracyclines Justin StebbingAlison JonesPeter Barrett-Lee Invited Commentary 03 January 2008 Pages: 451 - 453
Detection of the CHEK2 1100delC mutation by MLPA BRCA1/2 analysis: a worthwhile strategy for its clinical applicability in 1100delC low-frequency populations? Sara Gutiérrez-EnríquezJudith BalmañaOrland Díez Letter to the Editor 26 April 2007 Pages: 455 - 457
Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case–control study and a pooled meta-analysis Tanja LangsenlehnerWilfried RennerUwe Langsenlehner Letter to the Editor 24 April 2007 Pages: 459 - 460
